Dear reader, space exploration stands as one of the greatest challenges of our modern era. Scientists and engineers are ...

This new CHIPS platform provides a crucial technological bridge between foundational FRESH™ 3D bioprinting capabilities and ...

As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...

In the latest market close, CRISPR Therapeutics AG (CRSP) reached $39.11, with a +1.48% movement compared to the previous day. This move lagged the S&P 500's daily gain of 2.03%. At the same time, the ...

Plant biotechnology uses tools like genetic modification and bioengineering to enhance crops’ resilience, nutritional value, ...

Mark explains some of the regulation trends in the EU, compared with those in the USA and also shares his thoughts on what advances in biotech regulations we can expect to see in the next decade.

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

Tech companies have been getting a lot of attention in recent weeks during the up-and-down days on Wall Street. They ...

In a difficult climate for capital raisings, biotechs are turning to loans backed by their expected research and development tax refunds.

At DCAT 2025, Riccardo Butta, President of the Americas at Stevanato Group, discussed key innovations and strategies the company is employing to address the evolving landscape of drug delivery and ...